Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma

被引：0
|
作者：
Hiroshi Kurita
Etsuhide Yamamoto
Shinichi Nozaki
Shigehito Wada
Isao Furuta
Masaru Miyata
Kenji Kurashina
机构：
[1] Shinshu University School of Medicine,Department of Dentistry and Oral Surgery
[2] Kanazawa University Graduate School of Medical Science,Department of Oral and Maxillofacial Surgery
[3] National Hospital Organization Kanazawa Medical Center,Department of Oral and Maxillofacial Surgery
[4] University of Toyama,Department of Oral and Maxillofacial Surgery, Faculty of Medicine
[5] Ishikawa Prefectural Center Hospital,Department of Oral and Maxillofacial Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词：
Neoadjuvant chemotherapy; Squamous cell carcinoma; Docetaxel; Nedaplatin; Oral cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 508
页数：5
相关论文
共 50 条
  • [1] Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma
    Kurita, Hiroshi
    Yamamoto, Etsuhide
    Nozaki, Shinichi
    Wada, Shigehito
    Furuta, Isao
    Miyata, Masaru
    Kurashina, Kenji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 503 - 508
  • [2] Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma
    Kurita, H
    Yamamoto, E
    Nozaki, S
    Wada, S
    Furuta, I
    Kurashina, K
    ORAL ONCOLOGY, 2004, 40 (10) : 1000 - 1006
  • [3] Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell carcinoma of the lung
    Naito, Y.
    Kubota, K.
    Ohmatsu, H.
    Goto, K.
    Niho, S.
    Yoh, K.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2471 - 2475
  • [4] A single-institute phase I/II trial combining nedaplatin dose escalation with a fixed dose of docetaxel for induction chemotherapy of oral squamous cell carcinoma
    Miyazaki, Akihiro
    Kobayashi, Junichi
    Yamamoto, Takashi
    Kido, Yukie
    Takemura, Kanako
    Abe, Masato
    Tomihara, Kei
    Dehari, Hironari
    Nakamori, Kenji
    Nagai, Itaru
    Hiratsuka, Hiroyoshi
    ORAL ONCOLOGY, 2008, 44 (05) : 471 - 476
  • [5] Role of induction chemotherapy for oral cavity squamous cell carcinoma
    Abdelmeguid, Ahmed S.
    Silver, Natalie L.
    Boonsripitayanon, Mongkol
    Glisson, Bonnie S.
    Ferrarotto, Renata
    Gunn, G. Brandon
    Phan, Jack
    Gillenwater, Ann M.
    Hanna, Ehab Y.
    CANCER, 2021, 127 (17) : 3107 - 3112
  • [6] Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma
    Tanaka, Yoshihiro
    Yoshida, Kazuhiro
    Tanahashi, Toshiyuki
    Okumura, Naoki
    Matsuhashi, Nobuhisa
    Yamaguchi, Kazuya
    CANCER SCIENCE, 2016, 107 (06): : 764 - 772
  • [7] Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study
    Chang, Peter Mu-Hsin
    Lu, Hsueh-Ju
    Wang, Ling-Wei
    Tai, Shyh-Kuan
    Chen, Ming-Huang
    Chu, Pen-Yuan
    Yang, Muh-Hwa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (07): : 1333 - 1342
  • [8] Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
    Ohnuma, Hiroyuki
    Sato, Yasushi
    Hayasaka, Naotaka
    Matsuno, Teppei
    Fujita, Chisa
    Sato, Masanori
    Osuga, Takahiro
    Hirakawa, Masahiro
    Miyanishi, Koji
    Sagawa, Tamotsu
    Fujikawa, Koshi
    Ohi, Motoh
    Okagawa, Yutaka
    Tsuji, Yasushi
    Hirayama, Michiaki
    Ito, Tatsuya
    Nobuoka, Takayuki
    Takemasa, Ichiro
    Kobune, Masayoshi
    Kato, Junji
    CANCER SCIENCE, 2018, 109 (11): : 3554 - 3563
  • [9] Nedaplatin Plus Docetaxel Versus Cisplatin Plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung - A Multicenter, Open-label, Randomized, Phase III Trial
    Lu, Shun
    Chen, Zhiwei
    Hu, Chengping
    Zhang, Jian
    Chen, Yuan
    Song, Yong
    Zhao, Qiong
    Fan, Yun
    Wu, Gang
    Ma, Zhiyong
    Fang, Jian
    Yu, Qitao
    Liu, Zhe
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1743 - 1749
  • [10] Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
    Yajima, Satoshi
    Suzuki, Takashi
    Nanami, Tatsuki
    Oshima, Yoko
    Kikuchi, Yoshinori
    Funahashi, Kimihiko
    Shimada, Hideaki
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 27 (04) : 219 - 224
12345